Picture of Cansortium logo

TIUM.U Cansortium Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapTurnaround

Annual cashflow statement for Cansortium, fiscal year end - December 31st, millions except per share.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:
fx
Preliminary
FinalFinalFinalFinal
Net Income/Starting Line-65.6-36.6-19-37.1
Depreciation
Deferred Taxes
Non-Cash Items20.128.720.938.2
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital11.310.4-15.95.85
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-22.78.09-5.0319.1
Capital Expenditures-14.2-5.19-21.4-6.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-3.87-0.675-0.7320.025
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-18-5.87-22.1-6.77
Financing Cash Flow Items5100.162
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities41.3-1.5332.8-13
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.4960.8765.63-0.665